1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Development Resources
  5. Pivmecillinam – Oral Products
  1. Development Resources

Pivmecillinam – Oral Products

Exceptions or additions to the recognized standards

For disk diffusion, use paper disks impregnated with 10 mcg mecillinam.
Susceptibility interpretive criteria are based on a dose of 185 mg pivmecillinam orally three times a day.
Clinical efficacy was shown for Escherichia coli and Proteus mirabilis in patients with uncomplicated urinary tract infections.

Back to Top